Innovation. Experience. Results.
Home | 
About Us | 
Contact Us | 
The Process | 
Testimonials | 
Glossary | 
FAQS | 
Donations

News

Subscribe to Jawonio's Content Updates

Latest News

 
9.16:
9.16.20:
2020: Bruckner Oncology update
Analyses confirm 300% survival advantages and prognostic tests identify the 75% likely to benefit  For the MZB Foundation for Cancer Research: "GFLIO" regimens are based on a series of confirmed laboratory discoveries. The methods have reversed resistance to six critical, standard drugs (Anticancer Research 16, 18). ✔️As reported - accepted at three international meetings in 2020, another three hundred new patients with pancreatic,...read more

Comments (0) 

5.03:
5.03.18:
2018: Womens Cancers
Anticancer Research}women's cancers 60-80-100% response rates  Surg Clin NA} Neoadjuant twenty year survivors inoperable panc cancer  ESMO} in press Colon new available drugs repurposed survival  Research} updated Pancreatobiiliary updated safety eligibility survival }mscr in prep FDA  Research} updates Stomach SBC immunotherapy personalized medicine target drugs  survival Research} PARP BRCA 1/2 expanded to non BRCA and GI new co drugs  Vaccines} FDA cell immunity pancreatic cancer  GI oncology mscr...read more

Comments (0) 

4.23:
4.23.18:
Binah Magazine Article
 Please click on the download below for a link to the Binah Magazine article featuring Dr. Bruckner! 

Comments (0) 

1.01:
poster
1.01.17:
2017: Pancreatic Cancer
AACR} pancreatic safety survival confirmed expanded high risk patients  Vitamin C}personalized feasible assays broad application less invasive  ASCO} eligibility six diseases see progress report < ASCO 16 Reverse resistance feasible 100,000 patients benefit a year or more  Research} Personalized New hormones brain prostate panc 80% in vitro laboratory identified  Novel safety of high dose ascorbic acid and induction chemotherapy for high...read more

Comments (0) 

12.31:
12.31.16:
2016: Safety
AntiCancer Research} bile duct cholangiocarcinoma  target therapy new position confirm pancreatic asco 08 14 and gastric asco 06 expand role potency drugs 80% benefit  ASCO} safety relief vitamin C trial reduces half of preexisting limiting toxicity six cancers  Research} Update added Women's cancer confirm expand on AACR 14 Update added Hospice patients feasible majority live years > also > ASCO 17 >anticancer 18 Click on the...read more

Comments (0) 

11.27:
11.27.16:
Don't Download that Health App Just Yet
Mobile health applications have been growing in popularity but this doesn’t necessarily mean their effectiveness is improving. In fact, doctors have called for greater oversight and regulation when it comes to health apps as many have never been truly tested. A number of these apps also make false claims about...read more

Comments (0) 

10.06:
10.06.15:
Pancreatic cancer clinical trial-low dose chemo and Vitamin C
TITLE: A new trial tests a combination of Vitamin C and “core” low dose, chemotherapy to reproduce promising safety and efficacy findings in pancreatic cancer   Bruckner Oncology has initiated an FDA approved Phase II-III clinical trial which adds Vitamin C to chemotherapy "core" regimens (GFLIO and GFLIO-D)  for patients with locally...read more

Comments (1)  Last: 12/03 at 8:52 by [email protected]

10.22:
10.22.13:
MZB Cancer Research Foundation, Oncology Laboratory
MZB work has discovered a way to make unsafe and mediocre chemotherapy and smart target drugs both safer and more effective. The work has safely combined smart and cytotoxic drugs others have found very difficult to combine. The resulting responses include new safe therapeutic opportunities and possible cures for some...read more

Comments (0) 

 1   2  Next >>

Our Process

...read more